Cite
HARVARD Citation
Dieci, M. et al. (n.d.). Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer. Seminars in cancer biology. pp. 16-25. [Online].